Spectroscopic biomarkers track Huntington’s disease progression
Analysis recognises biochemical changes that are unique to Huntington’s
Scientists have established spectral fingerprints of Huntington’s disease biomarkers. The fingerprints, obtained using a combination of Raman spectroscopy and surface-enhanced Raman spectroscopy (Sers), could form the basis of a tool for assessing the effectiveness of therapies aimed at slowing down the disease’s onset and progression.